Growth Suppression by Acute Promyelocytic Leukemia-Associated Protein PLZF Is Mediated by Repression of c-myc Expression

Molecular and Cellular Biology

Volumn 23, Issue 24, 2003, Pages 9375-9388

  McConnell, Melanie J ^a   Chevallier, Nathalie ^a   Berkofsky Fessler, Windy ^a   Giltnane, Jena M ^b   Malani, Rupal B ^a   Staudt, Louis M ^b   Licht, Jonathan D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REPRESSOR PROTEIN; RETINOIC ACID RECEPTOR ALPHA; RNA POLYMERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PLZF; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL CYCLE; CELL GROWTH; CELL LEVEL; CELL SURVIVAL; CHROMOSOME TRANSLOCATION 11; CONTROLLED STUDY; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE REPRESSION; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOLECULAR INTERACTION; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WILD TYPE;

APOPTOSIS; BASE SEQUENCE; BINDING SITES; CELL CYCLE; CELL DIVISION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE EXPRESSION; GENES, MYC; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; U937 CELLS;

EID: 0344629425     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.24.9375-9388.2003     Document Type: Article

References (80)

1. Albert, T., J. Wells, J. O. Funk, A. Pullner, E. E. Raschke, G. Stelzer, M. Meisterernst, P. J. Farnham, and D. Eick. 2001. The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements. J. Biol. Chem. 276:20482-20490.
2. Alizadeh, A., M. Eisen, R. E. Davis, C. Ma, H. Sabet, T. Tran, J. I. Powell, L. Yang, G. E. Marti, D. T. Moore, J. R. Hudson, Jr., W. C. Chan, T. Greiner, D. Weisenburger, J. O. Armitage, I. Lossos, R. Levy, D. Botstein, P. O. Brown, and L. M. Staudt. 1999. The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harbor Symp. Quant. Biol. 64:71-78.
3. Alizadeh, A. A., M. B. Eisen, R. E. Davis, C. Ma, I. S. Lossos, A. Rosenwald, J. C. Boldrick, H. Sabet, T. Tran, X. Yu, J. I. Powell, L. Yang, G. E. Marti, T. Moore, J. Hudson, Jr., L. Lu, D. B. Lewis, R. Tibshirani, G. Sherlock, W. C. Chan, T. C. Greiner, D. D. Weisenburger, J. O. Armitage, R. Warnke, R. Levy, W. Wilson, M. R. Grever, J. C. Byrd, D. Botstein, P. O. Brown, and L. M. Staudt. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511.
4. Ball, H. J., A. Melnick, R. Shaknovich, R. A. Kohanski, and J. D. Licht. The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase. Nucleic Acids Res. 27:4106-4113.
5. Barna, M., N. Hawe, L. Niswander, and P. P. Pandolfi. 2000. Plzf regulates limb and axial skeletal patterning. Nat. Genet. 25:166-172.
6. Barrett, T. J., N. P. Sandhu, A. J. Tomlinson, L. M. Benson, M. Subramaniam, S. Naylor, and T. C. Spelsberg. 2000. Interactions of the nuclear matrix-associated steroid receptor binding factor with its DNA binding element in the c-myc gene promoter. Biochemistry 39:753-762.
7. Bartley, P. A., J. K. Lutwyche, and T. J. Gonda. 2001. Identification and validation of candidate Myb target genes. Blood Cells Mol. Dis. 27:409-415.
8. Batanian, J. R., E. Ma, Y. Huang, and B. Gadre. 2001. Co-existence of alternative forms of 8q gain in cytogenetic clones of three patients with acute myeloid leukemia, pointing to 8q22 approximately 8qter as a region of biologic significance. Cancer Genet. Cytogenet. 126:20-25.
9. Boer, J., J. Bonten-Surtel, and G. Grosveld. 1998. Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis. Mol. Cell. Biol. 18:1236-1247.
10. Bruckert, P., R. Kappler, H. Scherthan, H. Link, F. Hagmann, and H. Zankl. 2000. Double minutes and c-MYC amplification in acute myelogenous leukemia: are they prognostic factors? Cancer Genet. Cytogenet. 120:73-79.
11. Chen, Z., N. J. Brand, A. Chen, S. J. Chen, J. H. Tong, Z. Y. Wang, S. Waxman, and A. Zelent. 1993. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J. 12:1161-1167.
12. Chernukhin, I. V., S. Shamsuddin, A. F. Robinson, A. F. Carne, A. Paul, A. I. El-Kady, V. V. Lobanenkov, and E. M. Klenova. 2000. Physical and functional interaction between two pluripotent proteins, the Y-box DNA/RNA-binding factor, YB-1, and the multivalent zinc finger factor, CTCF. J. Biol. Chem. 275:29915-29921.
13. Cogswell, J. P., P. C. Cogswell, W. M. Kuehl, A. M. Cuddihy, T. M. Bender, U. Engelke, K. B. Marcu, and J. P.-Y. Ting. 1993. Mechanism of c-myc regulation by c-Myb in different cell lineages. Mol. Cell. Biol. 13:2858-2869.
14. Cole, M. D., and S. B. McMahon. 1999. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18:2916-2924.
15. Coller, H. A., C. Grandori, P. Tamayo, T. Colbert, E. S. Lander, R. N. Eisenman, and T. R. Golub. 2000. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl. Acad. Sci. USA 97:3260-3265.
16. Cook, M., A. Gould, N. Brand, J. Davies, P. Strutt, R. Shaknovich, J. Licht, S. Waxman, Z. Chen, S. Gluecksohn-Waelsch, et al. 1995. Expression of the zinc-finger gene PLZF at rhombomere boundaries in the vertebrate hind-brain. Proc. Natl. Acad. Sci. USA 92:2249-2253.
17. Dai, M. S., N. Chevallier, S. Stone, M. C. Heinrich, M. McConnell, T. Reuter, H. E. Broxmeyer, J. D. Licht, L. Lu, and M. E. Hoatlin. 2002. The effects of the Fanconi anemia zinc finger (FAZF) on cell cycle, apoptosis, and proliferation are differentiation stage-specific. J. Biol. Chem. 277:26327-26334.
18. Dang, C. V. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19:1-11.
19. Dang, C. V., L. M. Resar, E. Emison, S. Kim, Q. Li, J. E. Prescott, D. Wonsey, and K. Zeller. 1999. Function of the c-Myc oncogenic transcription factor. Exp. Cell Res. 253:63-77.
20. David, G., L. Alland, S. H. Hong, C. W. Wong, R. A. DePinho, and A. Dejean. 1998. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16:2549-2556.
21. Di Croce, L., V. A. Raker, M. Corsaro, F. Fazi, M. Fanelli, M. Faretta, F. Fuks, F. Lo Coco, T. Kouzarides, C. Nervi, S. Minucci, and P. G. Pelicci. 2002. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295:1079-1082.
22. Facchini, L. M., S. Chen, W. W. Marhin, J. N. Lear, and L. Z. Penn. 1997. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter. Mol. Cell. Biol. 17:100-114.
23. Feo, S., D. Arcuri, E. Piddini, R. Passantino, and A. Giallongo. 2000. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett. 473:47-52.
24. Freemantle, S. J., J. S. Kerley, S. L. Olsen, R. H. Gross, and M. J. Spinella. 2002. Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma. Oncogene 21:2880-2889.
25. Gartel, A. L., X. Ye, E. Goufman, P. Shianov, N. Hay, F. Najmabadi, and A. L. Tyner. 2001. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc. Natl. Acad. Sci. USA 98:4510-4515.
26. Ghosh, A. K., I. Grigorieva, R. Steele, R. G. Hoover, and R. B. Ray. 1999. PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation. Gene 235:85-91.
27. Grigorieva, I., V. G. Grigoriev, M. K. Rowney, and R. G. Hoover. 2000. Regulation of c-myc transcription by interleukin-2 (IL-2): identification of a novel IL-2 response element interacting with STAT-4. J. Biol. Chem. 275:7343-7350.
28. Grimwade, D., H. Walker, F. Oliver, K. Wheatley, C. Harrison, G. Harrison, J. Rees, I. Hann, R. Stevens, A. Burnett, and A. Goldstone. 1998. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 92:2322-2333.
29. Guo, Q. M., R. L. Malek, S. Kim, C. Chiao, M. He, M. Ruffy, K. Sanka, N. H. Lee, C.V. Dang, and E. T. Liu. 2000. Identification of c-myc responsive genes using rat cDNA microarray. Cancer Res. 60:5922-5928.
30. He, L., J. Liu, I. Collins, S. Sanford, B. O'Connell, C. J. Benham, and D. Levens. 2000. Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. EMBO J. 19:1034-1044.
31. He, L. Z., M. Bhaumik, C. Tribioli, E. M. Rego, S. Ivins, A. Zelent, and P. P. Pandolfi. 2000. Two critical hits for promyelocytic leukemia. Mol. Cell 6:1131-1141.
32. He, T. C., A. B. Sparks, C. Rago, H. Hermeking, L. Zawel, L. T. da Costa, P. J. Morin, B. Vogelstein, and K. W. Kinzler. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
33. Hoffman, B., A. Amanullah, M. Shafarenko, and D. A. Liebermann. 2002. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 21:3414-3421.
34. Hoffman, B., and D. A. Liebermann. 1998. The proto-oncogene c-myc and apoptosis. Oncogene 17:3351-3357.
35. Hummel, J. L., T. Zhang, R. A. Wells, and S. Kamel-Reid. 2002. The retinoic acid receptor alpha (RARα) chimeric proteins PML-, PLZF-, NPM-, and NuMA-RARα have distinct intracellular localization patterns. Cell Growth Differ. 13:173-183.
36. Itkes, A., C. J. Allegra, and M. Zajac-Kaye. 2000. Multiprotein complexes present at the MIF motifs flanking the promoter of the human c-myc gene. FEBS Lett. 474:23-28.
37. Johansen, L. M., A. Iwama, T. A. Lodie, K. Sasaki, D. W. Felsher, T. R. Golub, and D. G. Tenen. 2001. c-Myc is a critical target for C/EBPα in granulopoiesis. Mol. Cell. Biol. 21:3789-3806.
38. Kerley, J. S., S. L. Olsen, S. J. Freemantle, and M. J. Spinella. 2001. Transcriptional activation of the nuclear receptor corepressor RIP140 by retinoic acid: a potential negative-feedback regulatory mechanism. Biochem. Biophys. Res. Commun. 285:969-975.
39. Labbaye, C., M. T. Quaranta, A. Pagliuca, S. Militi, J. D. Licht, U. Testa, and C. Peschle. 2002. PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein. Oncogene 21:6669-6679.
40. Lee, K.-H., M.-Y. Chang, J.-I. Ahn, D.-H. Yu, S.-S. Jung, J.-H. Choi, Y.-H. Noh, Y.-S. Lee, and M.-J. Ahn. 2002. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Biochem. Biophys. Res. Commun. 296:1125-1133.
41. Lee, T. C., and E. B. Ziff. 1999. Mxi1 is a repressor of the c-Myc promoter and reverses activation by USF. J. Biol. Chem. 274:595-606.
42. Li, J. Y., M. A. English, H. J. Ball, P. L. Yeyati, S. Waxman, and J. D. Licht. 1997. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein. J. Biol. Chem. 272:22447-22455.
43. Li, L. H., C. Nerlov, G. Prendergast, D. MacGregor, and E. B. Ziff. 1994. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13:4070-4079.
44. Licht, J. D., R. Shaknovich, M. A. English, A. Melnick, J. Y. Li, J. C. Reddy, S. Dong, S. J. Chen, A. Zelent, and S. Waxman. 1996. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia. Oncogene 12:323-336.
45. Lin, R. J., L. Nagy, S. Inoue, W. Shao, W. H. Miller, Jr., and R. M. Evans. 1998. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391:811-814.
46. Lin, R. J., T. Sternsdorf, M. Tini, and R. M. Evans. 2001. Transcriptional regulation in acute promyelocytic leukemia. Oncogene 20:7204-7215.
47. Littlewood, T. D., D. C. Hancock, P. S. Danielian, M. G. Parker, and G. I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686-1690.
48. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10:142-153.
49. Lopez-Rodriguez, C., M. D. Delgado, A. Puig-Kroger, A. Nueda, E. Munoz, J. Leon, C. Bernabeu, and A. L. Corbi. 2000. c-Myc inhibits CD11a and CD11c leukocyte integrin promoters. Eur. J. Immunol. 30:2465-2471.
50. Melnick, A., K. F. Ahmad, S. Arai, A. Polinger, H. Ball, K. L. Borden, G. W. Carlile, G. G. Prive, and J. D. Licht. 2000. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Mol. Cell. Biol. 20:6550-6567.
51. Melnick, A., G. Carlile, K. F. Ahmad, C. L. Kiang, C. Corcoran, V. Bardwell, G. G. Prive, and J. D. Licht. 2002. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol. Cell. Biol. 22:1804-1818.
52. Melnick, A., and J. D. Licht. 1999. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93:3167-3215.
53. Melnick, A. M., J. J. Westendorf, A. Polinger, G. W. Carlile, S. Arai, H. J. Ball, B. Lutterbach, S. W. Hiebert, and J. D. Licht. 2000. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein. Mol. Cell. Biol. 20:2075-2086.
54. Menssen, A., and H. Hermeking. 2002. Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc. Natl. Acad. Sci. USA 99:6274-6279.
55. Miller, T. L., Y. Jin, J. M. Sun, A. S. Coutts, L. C. Murphy, and J. R. Davie. 1996. Analysis of human breast cancer nuclear proteins binding to the promoter elements of the c-myc gene. J. Cell. Biochem. 60:560-571.
56. Mitchell, K. O., and W. S. El-Deiry. 1999. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells. Cell Growth Differ. 10:223-230.
57. Neiman, P. E., A. Ruddell, C. Jasoni, G. Loring, S. J. Thomas, K. A. Brandvold, R. Lee, J. Burnside, and J. Delrow. 2001. Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius. Proc. Natl. Acad. Sci. USA 98:6378-6383.
58. Pandolfi, P. P. 2001. In vivo analysis of the molecular genetics of acute promyelocytic leukemia. Oncogene 20:5726-5735.
59. Ramana, C. V., N. Grammatikakis, M. Chernov, H. Nguyen, K. C. Goh, B. R. Williams, and G. R. Stark. 2000. Regulation of c-myc expression by IFN-γ through Stat1-dependent and -independent pathways. EMBO J. 19:263-272.
60. Redner, R. L. 2002. Variations on a theme: the alternate translocations in APL. Leukemia 16:1927-1932.
61. Reid, A., A. Gould, N. Brand, M. Cook, P. Strutt, J. Li, J. Licht, S. Waxman, R. Krumlauf, and A. Zelent. 1995. Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. Blood 86:4544-4552.
62. Rusiniak, M. E., M. Yu, D. T. Ross, E. C. Tolhurst, and J. L. Slack. 2000. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia. Cancer Res. 60:1824-1829.
63. Sakatsume, O., H. Tsutsui, Y. Wang, H. Gao, X. Tang, T. Yamauchi, T. Murata, K. Itakura, and K. K. Yokoyama. 1996. Binding of THZif-1, a MAZ-like zinc finger protein, to the nuclease-hypersensitive element in the promoter region of the c-MYC protooncogene. J. Biol. Chem. 271:31322-31333.
64. Schmidt, M., V. Nazarov, L. Stevens, R. Watson, and L. Wolff. 2000. Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis. Mol. Cell. Biol. 20:1970-1981.
65. Schuldiner, O., and N. Benvenisty. 2001. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Oncogene 20:4984-4994.
66. Sessarego, M., G. Fugazza, E. Balleari, R. Bruzzone, A. Ballestrero, and F. Patrone. 1997. High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. Cancer Genet. Cytogenet. 97:161-164.
67. Shaknovich, R., P. L. Yeyati, S. Ivins, A. Melnick, C. Lempert, S. Waxman, A. Zelent, and J. D. Licht. 1998. The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis. Mol. Cell. Biol. 18:5533-5545.
68. Simonsson, T., M. Pribylova, and M. Vorlickova. 2000. A nuclease hypersensitive element in the human c-myc promoter adopts several distinct itetraplex structures. Biochem. Biophys. Res. Commun. 278:158-166.
69. Spinella, M. J., J. S. Kerley, K. A. White, and J. C. Curtin. 2003. Retinoid target gene activation during induced tumor cell differentiation: human embryonal carcinoma as a model. J. Nutr. 133:273S-276S.
70. Truckenmiller, M. E., M. P. Vawter, C. Cheadle, M. Coggiano, D. M. Donovan, W. J. Freed, and K. G. Becker. 2001. Gene expression profile in early stage of retinoic acid-induced differentiation of human SH-SY5Y neuroblastoma cells. Restor. Neurol. Neurosci. 18:67-80.
71. Vial, J. P., F. X. Mahon, A. Pigneux, A. Notz, F. Lacombe, J. Reiffers, and C. Bilhou-Nabera. 2003. Derivative (7)t(7;8)(q34;q21), a new additional cytogenetic abnormality in acute promyelocytic leukemia. Cancer Genet Cytogenet. 140:78-81.
72. Vindigni, A., A. Ochem, G. Triolo, and A. Falaschi. 2001. Identification of human DNA helicase V with the far upstream element-binding protein. Nucleic Acids Res. 29:1061-1067.
73. 3 receptor. Blood 98:3290-3300.
74. Watson, J. D., S. K. Oster, M. Shago, F. Khosravi, and L. Z. Penn. 2002. Identifying genes regulated in a Myc-dependent manner. J. Biol. Chem. 277:36921-36930.
75. Wu, S., C. Cetinkaya, M. J. Munoz-Alonso, N. Von Der Lehr, F. Bahram, V. Beuger, M. Eilers, J. Leon, and L. G. Larsson. 2003. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22:351-360.
76. Yagi, K., M. Furuhashi, H. Aoki, D. Goto, H. Kuwano, K. Sugamura, K. Miyazono, and M. Kato. 2002. c-myc is a downstream target of the Smad pathway. J. Biol. Chem. 277:854-861.
77. Yeyati, P. L., R. Shaknovich, S. Boterashvili, J. Li, H. J. Ball, S. Waxman, K. Nason-Burchenal, E. Dmitrovsky, A. Zelent, and J. D. Licht. 1999. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18:925-934.
78. Zelent, A., F. Guidez, A. Melnick, S. Waxman, and J. D. Licht. 2001. Translocations of the RARα gene in acute promyelocytic leukemia. Oncogene 20:7186-7203.
79. Zhang, D., S. Vuocolo, V. Masciullo, T. Sava, A. Giordano, D. R. Soprano, and K. J. Soprano. 2001. Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression. Oncogene 20:7935-7944.
80. Zhao, X., and R. A. Spanjaard. 2003. The apoptotic action of the retinoid CD437/AHPN: diverse effects, common basis. J. Biomed. Sci. 10:44-49.